The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

Updated Efficacy Results for Avelumab in Metastatic Urothelial Carcinoma

Andrea B. Apolo, MD
Published Online:2:04 PM, Tue July 11, 2017

Andrea B. Apolo, MD, principal investigator and the head of the Bladder Cancer Section in the Genitourinary Malignancies Branch at the National Cancer Institute’s Center for Cancer Research, discusses a pooled analysis of 2 cohorts of the phase 1b JAVELIN trial, which is exploring avelumab (Bavencio) for the treatment of patients with metastatic urothelial carcinoma.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.